Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpha-tocopherol succinate is an esterified form of vitamin E (alpha-tocopherol), primarily used as a dietary supplement to treat or prevent vitamin E deficiency. It is hydrolyzed in the gastrointestinal tract to release free alpha-tocopherol for absorption. Alpha-tocopherol acts as an antioxidant and plays roles in immune function and cellular signaling. It inhibits protein kinase C activity involved in cell proliferation and differentiation and increases prostacyclin release from the endothelium to dilate blood vessels and inhibit platelet aggregation. While its main use is nutritional supplementation for deficiency states (such as fat-malabsorption disorders or abetalipoproteinemia), research has explored its potential anti-cancer properties due to effects on cell cycle regulation and apoptosis[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha-tocopherol succinate.